Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 925 of 1467 entries
View as:

Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06102005 Org: User:
Start: 10/16/23 End: 03/23/26 Due: 03/23/27

Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00464633 Org: User:
Start: 03/31/07 End: 12/31/11 Due: 12/31/12

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT06695130 Org: User:
Start: 11/18/24 End: 04/03/26 Due: 04/03/27

Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)

Phase: N/A Priority: Normal
NCT ID: NCT00115375 Org: User:
Start: 01/31/04 End: 04/30/06 Due: 04/30/07

A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06326814 Org: User:
Start: 10/11/21 End: 05/05/23 Due: 05/05/24

The Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT06975865 Org: User:
Start: 06/17/25 End: 12/29/28 Due: 12/29/29

Gene Expression and Tolerability Study of NV1FGF in Patients With Peripheral Artery Occlusive Disease Planned to Undergo Major Amputation

Phase: N/A Priority: Normal
NCT ID: NCT01157143 Org: User:
Start: 01/31/02 End: 10/31/03 Due: 10/31/04

A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression

Phase: N/A Priority: Normal
NCT ID: NCT00429260 Org: User:
Start: 01/31/07 End: 06/30/07 Due: 06/30/08

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01676220 Org: User:
Start: 08/31/12 End: 03/31/14 Due: 03/31/15

To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02057250 Org: User:
Start: 03/31/14 End: 03/31/16 Due: 03/31/17

Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT00305188 Org: User:
Start: 12/31/05 End: 10/31/09 Due: 10/31/10

LISA-study : Levothyroxin in Nodular Goiter

Phase: N/A Priority: Normal
NCT ID: NCT00277589 Org: User:
Start: 05/31/04 End: 12/31/08 Due: 12/31/09

Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01194882 Org: User:
Start: 11/16/10 End: 02/01/18 Due: 02/01/19

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications

Phase: N/A Priority: Normal
NCT ID: NCT02320721 Org: User:
Start: 01/31/15 End: 05/31/16 Due: 05/31/17

Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT02345070 Org: User:
Start: 05/01/15 End: 08/14/17 Due: 08/14/18

Enoxaparin in Acute Venous Thromboembolic Disease

Phase: N/A Priority: Normal
NCT ID: NCT00265993 Org: User:
Start: 12/31/04 End: 01/31/09 Due: 01/31/10

Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00553020 Org: User:
Start: 04/30/04 End: 07/31/05 Due: 07/31/06

A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf Region

Phase: N/A Priority: Normal
NCT ID: NCT05649813 Org: User:
Start: 11/20/22 End: 06/14/24 Due: 06/14/25

Safety, Tolerability and Pharmacokinetics of SAR231893 (REGN668) in Healthy Japanese Adult Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01537653 Org: User:
Start: 03/31/12 End: 10/31/12 Due: 10/31/13

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal Insulin

Phase: N/A Priority: Normal
NCT ID: NCT02967211 Org: User:
Start: 12/21/15 End: 10/20/17 Due: 10/20/18

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

Phase: N/A Priority: Normal
NCT ID: NCT00772928 Org: User:
Start: 10/31/03 End: 11/30/06 Due: 11/30/07

Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00545454 Org: User:
Start: 10/31/07 End: 06/30/08 Due: 06/30/09

Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05114590 Org: User:
Start: 01/27/22 End: 04/14/23 Due: 04/14/24

Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel

Phase: N/A Priority: Normal
NCT ID: NCT00637455 Org: User:
Start: 09/30/03 End: 01/31/05 Due: 01/31/06

Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00693771 Org: User:
Start: 04/30/08 End: 07/31/09 Due: 07/31/10